Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael W. Scherz"'
Autor:
Tiziana Bonifacino, Laura Micheli, Carola Torazza, Carla Ghelardini, Carlo Farina, Giambattista Bonanno, Marco Milanese, Lorenzo Di Cesare Mannelli, Michael W. Scherz
Publikováno v:
Cells, Vol 11, Iss 24, p 4027 (2022)
The racemic mixture dimiracetam negatively modulates NMDA-induced glutamate release in rat spinal cord synaptosomal preparations and is orally effective in models of neuropathic pain. In this study, we compared the effects of dimiracetam, its R- or S
Externí odkaz:
https://doaj.org/article/0de4dabf2e514ac0b215c48ef46c7c05
Publikováno v:
Journal of clinical pharmacology. 55(6)
Ponesimod is a selective S1P1 receptor modulator, and induces dose-dependent reduction of circulating lymphocytes upon oral dosing. Previous studies showed that single doses up to 75 mg or multiple doses up to 40 mg once daily are well tolerated, and
Autor:
Fialeix M, J B Fischer, Eckard Weber, A C Server, John F. W. Keana, Sonders Ms, Tester Bc, Michael W. Scherz, S. T. Wong, N. L. Reddy
Publikováno v:
Journal of medicinal chemistry. 33(9)
With an eye toward the development of novel atypical antipsychotic agents, we have studied the structure-affinity relationships of N,N'-di-o-tolylguanidine (DTG, 3) and its congeners at the haloperidol-sensitive sigma receptor. A number of DTG analog
Autor:
John M. Janusz, Patricia A. Young, Michael W. Scherz, Kevin Enzweiler, Laurence I. Wu, Lixian Gan, Stanislaw Pikul, Kelly L. McDow-Dunham, Carl R. Johnson, C. B. Senanayake, David E. Kellstein, Shelley A. Green, Jennifer L. Tulich, Theresa Rosario-Jansen, I. Jack Magrisso, Kenneth R. Wehmeyer, Deborah L. Kuhlenbeck, Thomas H. Eichhold, Roy L. M. Dobson
Publikováno v:
Journal of Medicinal Chemistry. 41:3102-3102
Autor:
Joseph S. Esherick, Mark S. Sonders, Joanne T. Adams, Barbara C. Tester, Michael W. Scherz, Peter M. Teal, Eckard Weber, John F. W. Keana
Publikováno v:
European Journal of Pharmacology. 142:61-71
Brain sigma-type receptors and phencyclidine receptors are thought to mediate the psychotomimetic effects of benzomorphans and phencyclidine in humans. Recently, we reported the characterization of a selective sigma receptor ligand, 1,3-di-o-tolyl-gu
Publikováno v:
Life sciences. 43(12)
A [3H]-labelled derivative of the drug (+)MK-801 with a high specific radioactivity was synthesized by first preparing a tribromo derivative of (+)MK-801 followed by catalytic reduction in the presence of [3H]-gas and subsequent purification of the r
Autor:
Robert N. McBurney, John F. W. Keana, Michael W. Scherz, C Jahr, Steven Finkbeiner, J B Fischer, P N Hamilton, S M Smith, Courtney Stevens, A C Server
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 86(14)
Four diarylguanidine derivatives were synthesized. These compounds were found to displace, at submicromolar concentrations, 3H-labeled 1-[1-(2-thienyl)cyclohexyl]piperidine and (+)-[3H]MK-801 from phencyclidine receptors in brain membrane preparation